Investment Pitches

Pitch Summary:
Lululemon is principally a designer, distributor, and retailer of healthy lifestyle inspired athletic apparel. It's moat is almost entirely based on its intangible brand asset. Of late, the company has benefited from both the longstanding athleisure fashion trend and the more recent pandemic-induced, work-from-home trend toward more casual attire. Approximately 45% of sales are generated across ~700 company-owned stores, 45% of sales (and growing rapidly) are generated online (lululemon.com), and ~10% of sales are generated by wholesale partners, which primarily comprise fitness studios. The stock's underperformance was concentrated around the F4Q earnings announcement, which saw the company meet expectations for the current quarter but provide cautious commentary regarding tepid US consumer spending behavior.

BSD Analysis:
Ithaka expresses concerns about Lululemon's near-term prospects despite acknowledging the company's strong brand moat and diversified sales channels. The fund recognizes Lululemon's successful positioning in the athleisure market and its ability to capitalize on pandemic-driven casual wear trends, with a balanced revenue mix between physical stores (45%), online sales (45%), and wholesale partners (10%). However, the investment thesis has turned cautious following disappointing earnings commentary about weakening US consumer spending patterns. The manager highlights that while Lululemon met quarterly expectations, management's forward-looking guidance reflected concerns about consumer behavior, leading to the stock's 23.6% decline and 0.7% negative portfolio impact. The fund appears concerned that Lululemon's premium positioning may face headwinds in a more challenging consumer environment. Despite the company's strong brand equity and omnichannel strategy, near-term execution risks and consumer spending uncertainty appear to outweigh the long-term growth potential in the manager's current assessment.

Pitch Summary:
Microsoft builds best-in-class platforms and provides services that help drive small business productivity, large business competitiveness, and public-sector efficiency. Microsoft's products include operating systems, cross-device productivity applications, server applications, software development tools, video games, and business-solution applications. The company also designs, manufactures, and sells devices, including PCs, tablets, and gaming/entertainment consoles that all integrate with Azure, its cloud computing service. In the quarter Microsoft's stock appreciated based on excitement surrounding the company's positioning in the generative AI market and its ability to monetize the coming wave of corporate investment in supercomputing and AI, which will be through both Azure and Microsoft Copilot, the company's new GenAI personal assistant.

BSD Analysis:
Ithaka maintains a bullish outlook on Microsoft, highlighting the company's comprehensive technology ecosystem and strategic positioning in the artificial intelligence revolution. The fund emphasizes Microsoft's diversified product portfolio spanning operating systems, productivity applications, cloud services, and gaming platforms, all integrated through the Azure cloud infrastructure. The investment thesis centers on Microsoft's ability to monetize the generative AI wave through two key channels: Azure's cloud computing capabilities for AI workloads and Microsoft Copilot, the company's AI-powered personal assistant. The manager notes strong quarterly performance driven by investor excitement about Microsoft's AI positioning and its potential to capture significant value from corporate AI investments. Microsoft's 12.1% return and 0.9% portfolio impact demonstrates solid execution during the period. The fund views Microsoft as uniquely positioned to benefit from the intersection of cloud computing and artificial intelligence, leveraging its existing enterprise relationships and comprehensive platform approach. This represents a high-quality growth play on the digital transformation and AI adoption trends.

Pitch Summary:
Founded in 1994, Amazon has evolved from its early roots as an online bookstore to become one of the world's largest eCommerce retailers. At the end of 2022 Amazon stood poised to capture ~40% of all US e-commerce sales, representing five times more share than the next closest competitor. In addition to eCommerce, Amazon Web Services ("AWS") has become the market leader in outsourced cloud infrastructure. Further, Amazon Advertising is garnering significant share in digital advertising, particularly product placement ads, thanks to consumers beginning their product searches on Amazon's site. Amazon's stock appreciated on the back of stabilization of the company's cloud computing segment and increased confidence the company would be able to contain expenses and push operating margins above prior peaks in the near-to-medium term.

BSD Analysis:
Ithaka presents a compelling bull case for Amazon based on the company's dominant market position across multiple high-growth segments. The fund emphasizes Amazon's commanding 40% share of US e-commerce, representing five times the market share of its nearest competitor, demonstrating significant competitive moats. The investment thesis extends beyond retail to include AWS's leadership in cloud infrastructure and the growing Amazon Advertising business, which benefits from consumers starting product searches directly on Amazon's platform. The manager highlights recent operational improvements, particularly the stabilization of AWS growth and management's ability to control expenses while expanding operating margins. Amazon's 18.6% quarterly return and 1.4% portfolio impact reflects strong execution during the period. The fund views Amazon as a diversified technology platform with multiple growth drivers rather than just an e-commerce retailer. This multi-faceted approach positions Amazon to benefit from secular trends in cloud adoption, digital advertising, and online commerce penetration.

Pitch Summary:
NVIDIA is the market leader in visual computing through the production of high-performance graphics processing units (GPUs). The company targets four large and growing markets: Gaming, Professional Visualization, Data Center, and Automotive. NVIDIA's products have the potential to lead and disrupt some of the most exciting areas of computing, including: data center acceleration, artificial intelligence (AI), machine learning, and autonomous driving. The reason for the stock's appreciation in the quarter was twofold: First, the stock benefited from tremendous excitement surrounding the further development of generative AI and the likelihood this would necessitate the purchase of a large number of Nvidia's products far into the future; Second, Nvidia posted another strong beat-and-raise quarter, where the company upped its F3Q24 revenue guidance above Street estimates, showcasing its dominant position in the buildout of tomorrow's computing infrastructure.

BSD Analysis:
Ithaka maintains a bullish stance on NVIDIA, emphasizing the company's dominant position in the GPU market and its strategic positioning for the AI revolution. The fund highlights NVIDIA's leadership across four key growth markets, with particular emphasis on data center acceleration and artificial intelligence applications. The investment thesis centers on NVIDIA's ability to capitalize on the generative AI boom, which should drive sustained demand for the company's high-performance computing products. The manager notes NVIDIA's consistent execution with another beat-and-raise quarter, demonstrating the company's ability to exceed expectations while raising forward guidance. NVIDIA's 84.4% quarterly return and 5.9% portfolio impact underscores its significance as a top contributor. The fund views NVIDIA as essential infrastructure for tomorrow's computing needs, positioning it to benefit from the multi-year AI investment cycle. This represents a high-conviction growth play on the transformative potential of artificial intelligence and machine learning technologies.

Pitch Summary:
PetIQ, Inc. is a United States based generic pet medication, supplements, and wellness services company. The Company operates as a value-added intermediary between club, big box retail, and ecommerce companies; pet pharmaceutical companies; and the consumer. PetIQ consists of two reportable business segments: product and services. The products segment, which constituted their original business, is a distribution operation that distributes over-the-counter and prescription pet pharmaceuticals to retailers. Subsequently, the organization has expanded to include a proprietary products business that manufactures PetIQ-branded generic and over-the-counter pharmaceuticals and supplements for distribution to pharmacies and retail stores. The services segment offers veterinary services at retail establishments. This segment is instrumental in stimulating consumer demand for high-profit, per-square-foot pet items and generates rental income for associated retailers. Notably, 50% of their customers have never visited a veterinarian prior to seeking services from a PetIQ facility. Underlying industry trend: Pet adoption increased significantly during Covid. After society reopened, the rest of the pet industry has suffered from a lull in pet spend and slowing growth in categories associated with the purchase of a new pet. Pet destruction has not increased, however. I believe, as pets age, medications and supplements and Primary care-like vet services, PetIQ's businesses, will continue to prosper. Over the past couple quarters, two more acute dynamics are occurring. More affluent customers continue to humanize their pets and spend on premium goods and services. Less than affluent customers are more acutely feeling the effect of inflation and are still spending on their pets, but are trading down. This dynamic favors PetIQs more cost effective products and services. Near/Medium Term PT: $45+ (Curr Price, $17.50). While many companies in the pet sector over-earned during Covid lockdowns, PETIQ benefits from a pet's continued existence - not just the initial purchase. The Company's growth algorithm is for 10% revenue growth, and 15% EBITDA growth. Whether valued as a distributor or as a branded merchandiser, the products division should be re-rated higher. The services business has under-earned since Covid, but that should end in the near term, resulting in improving ROIC and a better deserved valuation.

BSD Analysis:
White Brook Capital presents a compelling bull case for PetIQ, targeting a $45+ price from the current $17.50, representing 157% upside potential. The manager's thesis centers on PetIQ's defensive positioning in the pet healthcare market, benefiting from aging pet demographics rather than new pet adoption cycles that have pressured other pet companies post-COVID. The company operates two complementary segments: a products division manufacturing generic pet medications and supplements, and a services division providing veterinary care through retail partnerships. The investment rationale emphasizes PetIQ's cost-effective positioning during inflationary periods, as consumers trade down while maintaining pet spending. Management guides for 10% revenue growth and 15% EBITDA growth, with the services segment expected to recover margins from 13% to historical 20% levels as lower-margin wellness centers are replaced by higher-margin community clinics. The manager believes current street estimates are conservative, particularly for the tick/flea treatment business which represents 25% of product sales and shows strong early 2024 indicators.

Pitch Summary:
Weir Group PLC (WEIR LN) – International Weir is a focused mining technology company. Key products include slurry pumps and ESCO ground engaging tools. The company has undergone a simplification program since Jon Stanton became CEO in 2016. Jon sold Weir's Flow Control business in 2019 and its Oil & Gas business in 2021 in order to focus on the mining end market. Today, the business employs a razor/razor blade business model, enjoys high barriers to entry, and is highly resilient. The company's core value proposition to customers is lowest total cost of ownership, which it achieves by manufacturing products that operate more efficiently (using less energy and water) and last longer than alternatives. The cloud hovering over the stock revolves around mining end market concerns, particularly the dearth of large capex projects. We believe these concerns reflect a misunderstanding of Weir's business model. Weir's revenue and profitability are driven by the aftermarket, and the aftermarket is largely insensitive to mining capex cycles as evidenced by Weir's more than 7% aftermarket revenue compound annual growth rate (CAGR) from 2011-2023. Weir targets a mid-to-high single digit organic revenue growth CAGR through the cycle, driven by a favorable ore production backdrop and growing installed base. There is also an opportunity to improve the margin as management executes on its Performance Excellence program and generates operating leverage. All in, we believe double-digit EPS growth through the cycle is an attainable target. The valuation at just over 16 times forward earnings does not reflect the quality of the transformed Weir and through-cycle EPS growth potential.

BSD Analysis:
FMI's investment in Weir Group reflects confidence in the company's successful transformation into a focused mining technology leader under CEO Jon Stanton's strategic portfolio simplification. The fund's thesis centers on Weir's resilient razor/razor blade business model, where aftermarket revenues provide stability independent of mining capex cycles, as demonstrated by the 7%+ aftermarket CAGR from 2011-2023. Weir's competitive advantage stems from delivering lowest total cost of ownership through superior product efficiency and durability, creating high switching costs and barriers to entry. The market's focus on mining capex concerns misses the defensive nature of Weir's aftermarket-driven model, which benefits from a growing installed base and favorable long-term ore production trends. Management's Performance Excellence program offers additional margin expansion opportunities through operational improvements and leverage. With mid-to-high single-digit organic growth targets and margin enhancement potential, FMI sees a path to double-digit through-cycle EPS growth. At 16x forward earnings, the valuation fails to reflect the quality of the transformed business and its sustainable growth profile.

Pitch Summary:
Charles Schwab Corp. (SCHW) – Large Cap/All Cap We last wrote about Charles Schwab a year ago in the midst of the banking crisis. At the time, the worst fears were a bank run and/or balance sheet impairment. Positively, these did not come to pass. As a refresh of our interest in the business, Charles Schwab is a leading discount broker. The business benefits from long run market appreciation and Schwab's better mousetrap has allowed it to gain share on top of market growth, which has driven long run revenue growth of 10%. The competitive advantage comes from shared economies of scale, whereby Schwab lowers costs to the customer, thereby attracting new assets which then lets them lower costs even more to the customer. The rapid rise in interest rates that precipitated the banking crisis contributed to a challenging last 18 months for Schwab, as clients moved bank cash to higher yielding instruments. This led to a significant, albeit short-term, earnings headwind. As we move into 2024, we believe the worst is behind them. We expect Schwab will experience strong earnings growth for the next few years, driven by accelerating revenue growth and renewed expense discipline. Despite this attractive outlook, Schwab trades for 21 times trough earnings and only 14 times our estimate of normalized earnings.

BSD Analysis:
FMI maintains conviction in Charles Schwab following the 2023 banking crisis, viewing the worst-case scenarios of bank runs and balance sheet impairment as successfully navigated. The fund's investment thesis rests on Schwab's dominant market position in discount brokerage, supported by a powerful competitive moat through shared economies of scale that creates a virtuous cycle of cost reduction and asset attraction. The company's historical 10% revenue growth has been driven by both market appreciation and consistent market share gains. While rising interest rates created near-term headwinds as clients migrated cash to higher-yielding alternatives, FMI views this as a temporary earnings impact rather than a structural threat. The firm expects a strong earnings recovery driven by accelerating revenue growth and operational discipline as rate pressures normalize. At 21x trough earnings and 14x normalized earnings, Schwab offers compelling value for a market-leading franchise with secular growth tailwinds and operational leverage.

Pitch Summary:
Gates Industrial Corp. PLC (GTES) – Small Cap Gates manufactures highly engineered power transmission and fluid power solutions. The company is most well-known for its belts, which enable and control motion and are used in a broad range of applications. Blackstone took Gates public in early 2018 and remains the largest shareholder with a 27% ownership interest. Blackstone's ownership stake is an overhang on the stock as they will inevitably sell their remaining stake. Destocking and a more challenging end market have also weighed on results. These transitory pressures have provided us with an opportunity to own a high-quality, well-run industrial company with solid through-cycle growth prospects and re-rating potential. The company is a leader in its large and fragmented markets with a well-recognized brand known for quality and technological innovation. These markets are largely replacement driven, which helps to reduce cyclicality, and management is targeting a handful of growth opportunities including chain-to-belt conversions, personal mobility, and automotive aftermarket, to name a few, that should drive revenue growth at 2 times underlying industrial production growth. There is also a margin opportunity as management executes on internal initiatives to reduce costs and improve productivity. Finally, with Gates stock trading at around 12 times 2024 P/E, we believe there is an opportunity for Gates to re-rate more in-line with other high-quality industrial peers given its attractive EPS growth outlook and strong return profile.

BSD Analysis:
FMI presents a compelling value opportunity in Gates Industrial, a high-quality industrial manufacturer trading at attractive valuations due to temporary headwinds. The fund's thesis centers on Gates' market leadership in power transmission solutions, particularly belts, within large and fragmented markets that benefit from replacement-driven demand patterns. The company's defensive characteristics are enhanced by its focus on aftermarket revenues, which reduce cyclical exposure compared to pure industrial capex plays. Management's strategic growth initiatives, including chain-to-belt conversions and automotive aftermarket expansion, position the company to achieve revenue growth at 2x underlying industrial production rates. The margin expansion opportunity through operational excellence programs provides additional earnings leverage. At 12x 2024 P/E, Gates trades at a significant discount to industrial peers despite its superior market position and growth profile. The Blackstone overhang and near-term destocking pressures have created an attractive entry point for a quality industrial compounder with strong through-cycle prospects.

Pitch Summary:
Weir Group PLC (WEIR LN) – International Weir is a focused mining technology company. Key products include slurry pumps and ESCO ground engaging tools. The company has undergone a simplification program since Jon Stanton became CEO in 2016. Jon sold Weir's Flow Control business in 2019 and its Oil & Gas business in 2021 in order to focus on the mining end market. Today, the business employs a razor/razor blade business model, enjoys high barriers to entry, and is highly resilient. The company's core value proposition to customers is lowest total cost of ownership, which it achieves by manufacturing products that operate more efficiently (using less energy and water) and last longer than alternatives. The cloud hovering over the stock revolves around mining end market concerns, particularly the dearth of large capex projects. We believe these concerns reflect a misunderstanding of Weir's business model. Weir's revenue and profitability are driven by the aftermarket, and the aftermarket is largely insensitive to mining capex cycles as evidenced by Weir's more than 7% aftermarket revenue compound annual growth rate (CAGR) from 2011-2023. Weir targets a mid-to-high single digit organic revenue growth CAGR through the cycle, driven by a favorable ore production backdrop and growing installed base. There is also an opportunity to improve the margin as management executes on its Performance Excellence program and generates operating leverage. All in, we believe double-digit EPS growth through the cycle is an attainable target. The valuation at just over 16 times forward earnings does not reflect the quality of the transformed Weir and through-cycle EPS growth potential.

BSD Analysis:
FMI identifies Weir Group as a transformed mining technology company with a misunderstood business model that creates an attractive investment opportunity. Under CEO Jon Stanton's leadership since 2016, the company has simplified operations by divesting non-core businesses to focus on mining equipment and aftermarket services. The razor/razor blade model provides recurring revenue streams through aftermarket services, which demonstrated resilience with 7% CAGR from 2011-2023 despite mining capex volatility. Market concerns about mining capex cycles appear overblown given the aftermarket-driven revenue base and growing installed base. Management targets mid-to-high single-digit organic growth with margin expansion through operational excellence initiatives. The 16x forward earnings multiple appears attractive for a business capable of double-digit EPS growth through the cycle, suggesting significant re-rating potential as investors recognize the transformation.

Pitch Summary:
Charles Schwab Corp. (SCHW) – Large Cap/All Cap We last wrote about Charles Schwab a year ago in the midst of the banking crisis. At the time, the worst fears were a bank run and/or balance sheet impairment. Positively, these did not come to pass. As a refresh of our interest in the business, Charles Schwab is a leading discount broker. The business benefits from long run market appreciation and Schwab's better mousetrap has allowed it to gain share on top of market growth, which has driven long run revenue growth of 10%. The competitive advantage comes from shared economies of scale, whereby Schwab lowers costs to the customer, thereby attracting new assets which then lets them lower costs even more to the customer. The rapid rise in interest rates that precipitated the banking crisis contributed to a challenging last 18 months for Schwab, as clients moved bank cash to higher yielding instruments. This led to a significant, albeit short-term, earnings headwind. As we move into 2024, we believe the worst is behind them. We expect Schwab will experience strong earnings growth for the next few years, driven by accelerating revenue growth and renewed expense discipline. Despite this attractive outlook, Schwab trades for 21 times trough earnings and only 14 times our estimate of normalized earnings.

BSD Analysis:
FMI maintains conviction in Charles Schwab following the 2023 banking crisis, viewing recent challenges as temporary headwinds rather than structural issues. The manager highlights Schwab's competitive moat through economies of scale that enable continuous cost reduction, driving market share gains and historical 10% revenue growth. The interest rate shock that caused client cash migration to higher-yielding instruments created near-term earnings pressure but represents a cyclical rather than permanent impairment. FMI expects strong earnings recovery driven by accelerating revenue growth and expense discipline as rate pressures normalize. The valuation appears attractive at 21x trough earnings and 14x normalized earnings, suggesting significant upside as the business returns to normalized profitability. The investment thesis relies on Schwab's durable competitive advantages and cyclical recovery potential.

Pitch Summary:
Gates Industrial Corp. PLC (GTES) – Small Cap Gates manufactures highly engineered power transmission and fluid power solutions. The company is most well-known for its belts, which enable and control motion and are used in a broad range of applications. Blackstone took Gates public in early 2018 and remains the largest shareholder with a 27% ownership interest. Blackstone's ownership stake is an overhang on the stock as they will inevitably sell their remaining stake. Destocking and a more challenging end market have also weighed on results. These transitory pressures have provided us with an opportunity to own a high-quality, well-run industrial company with solid through-cycle growth prospects and re-rating potential. The company is a leader in its large and fragmented markets with a well-recognized brand known for quality and technological innovation. These markets are largely replacement driven, which helps to reduce cyclicality, and management is targeting a handful of growth opportunities including chain-to-belt conversions, personal mobility, and automotive aftermarket, to name a few, that should drive revenue growth at 2 times underlying industrial production growth. There is also a margin opportunity as management executes on internal initiatives to reduce costs and improve productivity. Finally, with Gates stock trading at around 12 times 2024 P/E, we believe there is an opportunity for Gates to re-rate more in-line with other high-quality industrial peers given its attractive EPS growth outlook and strong return profile.

BSD Analysis:
FMI presents a compelling value opportunity in Gates Industrial, a leading manufacturer of power transmission belts and fluid power solutions. The manager identifies temporary headwinds including Blackstone's ownership overhang and cyclical destocking that have created an attractive entry point. The investment thesis centers on Gates' market leadership position in large, fragmented markets with replacement-driven demand that reduces cyclicality. Management's growth initiatives targeting chain-to-belt conversions, personal mobility, and automotive aftermarket are expected to drive revenue growth at 2x underlying industrial production. The company trades at an attractive 12x 2024 P/E multiple, providing re-rating potential as margins expand through cost reduction initiatives and operational improvements. FMI views this as a high-quality industrial with solid through-cycle prospects trading at a discount to peers.

Pitch Summary:
e.l.f. Beauty, in the consumer staples sector, is a mass cosmetics and skincare provider in the U.S., selling professional-quality makeup and skincare products at an attractive price point relative to legacy brands. With a significant online, direct-to-consumer presence and clean product ingredients, the company has been a strong market share gainer with multiple levers to sustain elevated growth.

BSD Analysis:
ClearBridge's e.l.f. Beauty investment targets a disruptive mass cosmetics company gaining market share through value positioning and modern distribution strategies. The manager values the company's ability to offer professional-quality products at attractive price points compared to legacy brands, appealing to cost-conscious consumers without sacrificing quality. The significant direct-to-consumer online presence provides higher margins, better customer data, and reduced dependence on traditional retail channels. Clean product ingredients align with consumer trends toward healthier beauty products, differentiating e.l.f. from traditional mass market competitors. The company's strong market share gains demonstrate effective execution and brand resonance with target demographics. Multiple growth levers suggest sustainable competitive advantages and expansion opportunities beyond the current product portfolio. The manager appears confident in e.l.f.'s ability to continue disrupting the traditional beauty industry through innovation, value positioning, and digital-first marketing strategies.

Pitch Summary:
Duolingo, in the consumer discretionary sector, is a category leader in online language learning. With a freemium digital education model offering 40+ languages, Duolingo's application has exhibited rapid growth in users and conversion to paid subscribers. The company has opportunity to expand its English-learning focus as well as broaden into new categories like math and music. Duolingo offers a long history of product innovation, marketing efficiency and attractive profitability/unit economics.

BSD Analysis:
ClearBridge's Duolingo investment capitalizes on the leading position in the growing online language learning market. The manager values the freemium model's effectiveness in driving rapid user growth and converting free users to paid subscribers, demonstrating strong product-market fit across 40+ languages. The investment thesis includes significant expansion opportunities beyond core language learning into adjacent categories like math and music, which could substantially increase the total addressable market. The company's track record of product innovation and marketing efficiency suggests strong execution capabilities and sustainable competitive advantages. Attractive unit economics indicate scalable business model characteristics with improving profitability as the user base grows. The English-learning focus provides particular growth opportunities in international markets where English proficiency drives economic advancement. The manager appears confident in Duolingo's ability to maintain category leadership while expanding into new educational verticals and geographic markets.

Pitch Summary:
Intapp, in the IT sector, is a vertical software provider with a leading position serving the professional and financial services industry. Its tailored offerings provide enterprise resource planning, customer relationship management and compliance solutions, tailored specifically for these verticals. We see significant runway to expand the modules sold to their existing clients, supporting robust growth and expanding margins.

BSD Analysis:
ClearBridge's Intapp investment targets a specialized vertical software provider with dominant positioning in professional and financial services markets. The manager values the company's tailored approach to enterprise resource planning, customer relationship management, and compliance solutions specifically designed for these industries. This vertical specialization creates high switching costs and deep client relationships, supporting pricing power and revenue retention. The investment thesis centers on significant cross-selling opportunities to expand modules sold to existing clients, which should drive robust growth with minimal customer acquisition costs. The land-and-expand model typically generates expanding margins as additional modules leverage existing client relationships and infrastructure. Professional and financial services firms have complex regulatory and operational requirements that favor specialized solutions over generic software platforms. The manager sees substantial runway for growth as clients adopt additional modules and the company potentially expands into adjacent verticals or geographic markets.

Pitch Summary:
Insmed is a biopharmaceutical company focused primarily on rare pulmonary diseases. The company has an approved and marketed product still growing in domestic and international markets, along with opportunities to expand its initial indication. Moreover, the company has several late-stage clinical candidates with blockbuster sales potential.

BSD Analysis:
ClearBridge's Insmed investment focuses on a specialized biopharmaceutical company with established commercial success in rare pulmonary diseases. The manager values the company's existing approved product that continues to demonstrate growth in both domestic and international markets, providing current revenue generation and cash flow. The investment thesis includes significant expansion opportunities through label expansion of the existing product into additional indications, which could substantially increase the addressable market. The manager highlights multiple late-stage clinical candidates with blockbuster sales potential, suggesting a robust pipeline that could drive future growth beyond the current commercial product. Rare disease focus typically provides pricing power and limited competition, supporting attractive margins and market exclusivity. The combination of current commercial success with significant pipeline optionality creates multiple value creation pathways. International expansion opportunities add geographic diversification and additional growth levers for the existing product portfolio.

Pitch Summary:
Medpace provides outsourced clinical research drug development services to the pharmaceutical and biotechnology sectors. Medpace's full-service focus on small-midsize biotech customers should allow it to post above-peer growth with strong profitability and cash flow generation.

BSD Analysis:
ClearBridge's Medpace investment targets the growing clinical research outsourcing market with a differentiated customer focus strategy. The manager values Medpace's specialization in serving small-to-midsize biotech companies, which typically offer higher growth rates and less pricing pressure compared to large pharmaceutical clients. This customer segmentation strategy should enable above-peer growth rates as smaller biotech companies increasingly outsource clinical development to manage costs and access specialized expertise. The full-service model provides comprehensive solutions and deeper client relationships, supporting revenue retention and expansion opportunities. Strong profitability and cash flow generation indicate efficient operations and pricing power within the target market segment. The manager appears confident in Medpace's ability to capitalize on the continued growth in biotech funding and drug development activity. The CRO industry benefits from increasing R&D outsourcing trends and regulatory complexity, supporting long-term demand visibility.

Pitch Summary:
RadNet owns and operates outpatient freestanding diagnostic imaging centers. The market is seeing secular growth from a shift in the site of care from the more expensive inpatient setting to freestanding imaging centers like RadNet. With solid organic growth, coupled with an attractive de novo and acquisition opportunity, the company has a long runway to compound topline growth. RadNet has also invested heavily in newer AI applications that can provide an additional revenue stream, while also improving the early identification of cancers.

BSD Analysis:
ClearBridge's RadNet investment capitalizes on a secular healthcare trend toward cost-effective outpatient care delivery. The manager identifies the structural shift from expensive inpatient settings to freestanding imaging centers as a key growth driver, providing RadNet with expanding market share opportunities. The investment thesis combines organic growth with strategic expansion through both de novo center development and acquisitions, creating multiple avenues for revenue compounding. The company's AI investment strategy adds a differentiated technology component that generates additional revenue streams while improving clinical outcomes through enhanced cancer detection capabilities. This dual benefit of revenue generation and improved patient care creates competitive advantages and potential margin expansion. The manager views RadNet as well-positioned to benefit from healthcare cost containment pressures while maintaining quality care standards. The long runway for topline growth suggests sustainable competitive positioning in a consolidating market.

Pitch Summary:
CONMED is a medical device provider focusing on the orthopedic and general surgery categories. The business is balanced globally with over 80% of revenues coming from single-use products. CONMED has a handful of high-growth products, with competitive differentiation, early in their penetration.

BSD Analysis:
ClearBridge's investment in CONMED centers on the company's focused medical device portfolio in orthopedic and general surgery markets. The manager values the business model's stability with over 80% of revenues derived from single-use products, providing recurring revenue characteristics and reducing customer concentration risk. The global diversification offers geographic balance and growth opportunities across different healthcare markets. The investment thesis emphasizes CONMED's competitive differentiation through high-growth products that are still early in their market penetration cycle. This suggests significant runway for market share expansion and revenue growth. The manager appears to favor the company's specialized focus rather than a broad medical device conglomerate approach. The timing indicates confidence in the company's ability to execute on product launches and market expansion initiatives.

Pitch Summary:
Viking Therapeutics is focused on metabolic and endocrine diseases. While still early stage, the company has had positive Phase 2 data on a GLP-1/GIP agonist injectable candidate potentially differentiated in mechanism with encouraging results relative to existing approved/pipeline candidates. The company is also pursuing an oral obesity GLP-1/GIP treatment and has a Phase 2 compound to treat nonalcoholic fatty liver disease, or NASH. Given the strong growth potential in the obesity market, multiple potential products and scarcity value in the small cap universe, we believe this is an attractive potential opportunity with sufficient capital to support near-term clinical development goals.

BSD Analysis:
ClearBridge views Viking Therapeutics as an attractive early-stage biotech opportunity in the high-growth obesity treatment market. The manager highlights the company's differentiated GLP-1/GIP agonist injectable candidate with encouraging Phase 2 results compared to existing competitors. The investment thesis centers on multiple product opportunities including an oral obesity treatment and a NASH compound, providing diversified revenue potential. The manager emphasizes the scarcity value of small-cap exposure to the obesity market, which is experiencing strong secular growth. Viking's sufficient capital position supports near-term clinical development milestones without immediate dilution concerns. The timing of the investment appears strategic, as the manager purchased the position in March after missing earlier benchmark performance. This represents a quality growth story with multiple catalysts in a large addressable market.

Pitch Summary:
Weir Group PLC (WEIR LN) – International Weir is a focused mining technology company. Key products include slurry pumps and ESCO ground engaging tools. The company has undergone a simplification program since Jon Stanton became CEO in 2016. Jon sold Weir's Flow Control business in 2019 and its Oil & Gas business in 2021 in order to focus on the mining end market. Today, the business employs a razor/razor blade business model, enjoys high barriers to entry, and is highly resilient. The company's core value proposition to customers is lowest total cost of ownership, which it achieves by manufacturing products that operate more efficiently (using less energy and water) and last longer than alternatives. The cloud hovering over the stock revolves around mining end market concerns, particularly the dearth of large capex projects. We believe these concerns reflect a misunderstanding of Weir's business model. Weir's revenue and profitability are driven by the aftermarket, and the aftermarket is largely insensitive to mining capex cycles as evidenced by Weir's more than 7% aftermarket revenue compound annual growth rate (CAGR) from 2011-2023. Weir targets a mid-to-high single digit organic revenue growth CAGR through the cycle, driven by a favorable ore production backdrop and growing installed base. There is also an opportunity to improve the margin as management executes on its Performance Excellence program and generates operating leverage. All in, we believe double-digit EPS growth through the cycle is an attainable target. The valuation at just over 16 times forward earnings does not reflect the quality of the transformed Weir and through-cycle EPS growth potential.

BSD Analysis:
FMI presents a compelling case for Weir Group as a misunderstood mining technology leader trading at a significant discount to its intrinsic value. Under CEO Jon Stanton's leadership since 2016, the company has successfully transformed into a focused mining specialist through strategic divestitures, creating a resilient razor/razor blade business model with high barriers to entry. The manager emphasizes that market concerns about mining capex cycles reflect a fundamental misunderstanding of Weir's aftermarket-driven revenue model, which has demonstrated remarkable consistency with 7%+ CAGR from 2011-2023. The company's value proposition of lowest total cost of ownership through superior efficiency and durability creates strong customer loyalty and pricing power. With favorable ore production trends and a growing installed base supporting mid-to-high single-digit organic growth, combined with margin expansion opportunities from the Performance Excellence program, FMI targets double-digit EPS growth through the cycle. At 16x forward earnings, the valuation fails to reflect the quality of the transformed business model.